|
Авторизація
|
Американські ринки не судинних стентів (U.S. Markets for Nonvascular Stents) Nonvascular stenting has been used for decades in the palliation of transient and chronic obstructions of natural circulatory pathways that enable the transfer of air, bodily fluids, and other substances involved in systemic metabolic and energy exchange. These circulatory pathways include the biliary tree as well as the gastrointestinal (GI), pulmonary, and urinary tracts. In 2010, nonvascular stenting systems were used in approximately 516,500 endoluminal recanalization procedures in the U.S., generating an estimated $168.8 million in related sales. Over the forecast period covered by this report, the number of nonvascular stenting procedures in the U.S. is expected to increase at a compound annual rate of 1.5%; during the same period, corresponding dollar sales are expected to increase at a compound annual rate of 2.8%, reaching approximately $189.2 million in the year 2014.
Publisher: Medtech Insight
This new report by Medtech Insight includes analyses of products, technologies, current and forecast markets, competitors, and opportunities in the U.S. nonvascular stents market. Major topics covered by this report include a discussion of current and emerging nonvascular stenting technologies; a clinical overview of nonvascular conditions targeted by stenting (e.g., biliary GI, pulmonary, and urinary tract obstruction) and an analysis of the procedure volumes and market forecasts for biliary, GI, pulmonary, and urologic stenting systems in the U.S. TABLE OF CONTENTS EXECUTIVE SUMMARY a. Nonvascular Stenting Systems b. Stent Design and Materials c. Products and Procedures i. Biliary Stenting ii. Gastrointestinal Stenting iii. Pulmonary Stenting iv. Urologic Stenting v. Combined Procedure Volumes Forecast d. Market Analysis i. Biliary Stents ii. Gastrointestinal Stents iii. Pulmonary Stents iv. Urologic Stents v. Combined Market Analysis Exhibit ES-1: 2010, Estimated Incidence of Nonvascular Conditions Targeted by Stenting Technologies Exhibit ES-2: Nonvascular Stenting, Procedure Volumes Forecast, 2009-2014 Exhibit ES-3: Nonvascular Stenting Systems, Market Forecast, 2009-2014 1. CURRENT AND EMERGING PERIPHERAL VASCULAR AND NONVASCULAR STENTING TECHNOLOGIES 1.1 Stent Design 1.1.1 Vascular Stents1.2 Stent Materials 1.2.1 Metal Stents1.3 Stent Coatings 1.3.1 Radiopacity EnhancementExhibit 1-1: Selected Biomedical, Clinical, and Technical Stent Requirements Exhibit 1-2: Advantages and Disadvantages of Selected Vascular Stent Designs Exhibit 1-3: Advantages and Disadvantages of Metal Stent Materials Exhibit 1-4: Selected Polymeric Stent Materials Exhibit 1-5: Selected Characteristics of Antirestenosis Agents Used in Drug-Eluting Stents Exhibit 1-6: Advantages and Disadvantages of Nonresorbable and Biodegradable Polymeric Drug Carriers for Drug-Eluting Stents 2. CLINICAL OVERVIEW OF NONVASCULAR STENTS 2.1 Nonvascular Conditions Targeted by Stenting 2.1.1 Biliary Tract ObstructionExhibit 2-1: 2010, Biliary Obstruction, Facts and Figures Exhibit 2-2: Biliary Stenting, Procedure Volumes Forecast, 2009-2014 Exhibit 2-3: 2010, Colorectal Obstruction, Facts and Figures Exhibit 2-4: 2010, Esophageal Obstruction, Facts and Figures Exhibit 2-5: Gastrointestinal Stenting, Procedure Volumes Forecast, 2009-2014 Exhibit 2-6: 2010, Pulmonary Tract Obstruction, Facts and Figures Exhibit 2-7: Pulmonary Stenting, Procedure Volumes Forecast, 2009-2014 Exhibit 2-8: 2010, Upper Urinary Tract Obstruction, Facts and Figures Exhibit 2-9: 2010, Lower Urinary Tract Obstruction, Facts and Figures Exhibit 2-10: Urologic Stenting, Procedure Volumes Forecast, 2009-2014 3. NONVASCULAR STENTS MARKET 3.2.1 Biliary Stenting Systems 3.2.1.1 Products3.2.2 Gastrointestinal Stenting Systems 3.2.2.1 Products3.2.3 Pulmonary Stenting Systems 3.2.3.1 Products3.2.4 Urologic Stenting Systems 3.2.4.1 Ureteral Stenting ProductsExhibit 3-1: Nonvascular Stenting, Procedure Volumes Forecast, 2009-2014 Exhibit 3-2: Nonvascular Stents, Market Forecast, 2009-2014 Exhibit 3-3: 2011, Selected Metal and Plastic Biliary Stents Exhibit 3-4: Biliary Stents, Market Forecast, 2009-2014 Exhibit 3-5: 2010, Biliary Stents Market, Share by Supplier Exhibit 3-6: 2011, Selected Colorectal Stents Exhibit 3-7: 2011, Selected Esophageal Stents Exhibit 3-8: Metal Gastrointestinal Stents, Market Forecast, 2009-2014 Exhibit 3-9: 2010, Colorectal Stents Market, Share by Supplier Exhibit 3-10: 2010, Metal Esophageal Stents Market, Share by Supplier Exhibit 3-11: 2011, Selected Pulmonary Stents Exhibit 3-12: Pulmonary Stents, Market Forecast, 2009-2014 Exhibit 3-13: 2010, Pulmonary Stents Market, Share by Supplier Exhibit 3-14: 2011, Selected Ureteral Stents Exhibit 3-15: 2011, Selected Prostatic Stents Exhibit 3-16: Urologic Stents, Market Forecast, 2009-2014 Exhibit 3-17: 2010, Ureteral Stents Market, Share by Supplier Exhibit 3-18: 2010, Urethral Stents Market, Share by Supplier 4. COMPANY PROFILES 4.1 AbbeyMoor Medical, Inc. 4.2 American Medical Systems, Inc. 4.3 Boston Scientific Corporation 4.4 Bryan Corporation 4.5 Cook Group, Inc. 4.6 Cordis Corporation/Johnson & Johnson 4.7 Gyrus ACMI/Olympus Corporation 4.8 Hood Laboratories, Inc. 4.9 Merit Endotek/Merit Medical Systems, Inc. Перекладач: translate.google.com |
Новини
03.03.2023 Науково доведено: через смартфони ви можете старіти швидше
24.02.2023 Стимуляція спинного мозку відновлює постінсультну функцію рук 17.02.2023 Вчені відкрили здатність жирної їжі руйнувати мозок 10.02.2023 В Індії розробили неінвазивний тест, який використовує штучний інтелект для виявлення раку молочної залози 01.02.2023 Як спостереження за світанками та заходами сонця впливає на здоров'я – вчені 25.01.2023 Аналіз крові для ранньої діагностики хвороби Альцгеймера розробили вчені 18.01.2023 Людина з серцем свині. Пацієнту вперше пересадили серце тварини 11.01.2023 Вчені пояснили, чому оливкову олію варто пити ложками 21.11.2022 Вчені виявили ще одну причину високого ризику атеросклерозу 18.11.2022 Імплантована помпа доставила протиракові ліки у пухлини мозку 16.11.2022 Шум вночі може бути причиною безсоння та серцево-судинних захворювань 14.11.2022 ЩО ТРЕБА ЗНАТИ ПРО ЦУКРОВИЙ ДІАБЕТ: ТИПИ, СИМПТОМИ, УСКЛАДНЕННЯ 11.11.2022 Виявилося, в епідемії ожиріння винен лише один тип їжі 09.11.2022 Проказа: давня хвороба, здатна регенерувати органи 07.11.2022 "Чарівні гриби" можуть лікувати важку депресію 04.11.2022 Нове випробування пропонує переваги CV з EPA: RESPECT-EPA 02.11.2022 Майже 500 українських медиків завершили навчання з тактичної медицини 01.11.2022 Чи можна людям з діабетом пити алкоголь 31.10.2022 Знайдено овоч, здатний знизити цукор у крові відразу на 20% 28.10.2022 Людська печінка може працювати 100 років |